| For: | Ray G. Management of liver diseases: Current perspectives. World J Gastroenterol 2022; 28(40): 5818-5826 [PMID: 36353204 DOI: 10.3748/wjg.v28.i40.5818] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v28/i40/5818.htm |
| Number | Citing Articles |
| 1 |
Jitendra Patel, Harekrishna Roy, Deepak S. Khobragade, Surendra Agrawal, Nihar Ranjan Das, Rukmani Patel, Vijay Patel, Poonam Lal. Natural lipid-based nanoformulations for enhancing hepatoprotective activity: mechanisms, efficacy, and clinical translation. Health Nanotechnology 2025; 1(1) doi: 10.1186/s44301-025-00010-8
|
| 2 |
Milena Georgieva, Charilaos Xenodochidis, Natalia Krasteva. Old age as a risk factor for liver diseases: Modern therapeutic approaches. Experimental Gerontology 2023; 184 doi: 10.1016/j.exger.2023.112334
|
| 3 |
Yihan Liu, Haojie Xue, Yang Liu, Han Li, Qian Liang, Longhui Ma, Ming Zhao, Junying Liu. Serum Insulin-Like Growth Factor 1 and the Prognosis of Patients With Advanced Liver Diseases: A Meta-Analysis. Clinical and Translational Gastroenterology 2025; 16(7) doi: 10.14309/ctg.0000000000000829
|
| 4 |
Antoine Dumoutier, Aymeric Nicolas, Baptiste Bonnet, Yann Touchefeu, Jeremy Meyer, Frederic Douane, Eric Frampas, Lambros Tselikas, Arthur David. Percutaneous thermal ablation in hepatocellular carcinoma patients with and without TIPS. Abdominal Radiology 2024; 50(5) doi: 10.1007/s00261-024-04655-4
|
| 5 |
F. V. Hladkykh, I. V. Bielochkina, I. V. Koshurba, M. O. Chyzh. Modern hepatoprotection: a narrative review of existing approaches and prospects for the use of biotechnological drugs. Modern medical technology 2023; (3) doi: 10.34287/MMT.3(58).2023.9
|
| 6 |
Gaurav Mittal, Prashanth A, Arkadeep Dhali, Roshan Prasad, Yogesh S, Khulud Mahmood Nurani, Mihnea-Alexandru Găman. Plant extracts with antioxidant and hepatoprotective benefits for liver health: A bibliometric analysis of drug delivery systems. World Journal of Gastroenterology 2025; 31(18): 105836 doi: 10.3748/wjg.v31.i18.105836
|
| 7 |
Giuseppe Guido Maria Scarlata, Ivo Lopez, Maria Luisa Gambardella, Maja Milanović, Nataša Milić, Ludovico Abenavoli. Preventive and Therapeutic Effects of Baicalein, Galangin, and Isorhamnetin in Chronic Liver Diseases: A Narrative Review. Molecules 2025; 30(6) doi: 10.3390/molecules30061253
|
| 8 |
Sumbul Qidwai, Asad Ahmad, Mohammad Shariq, Anas Islam, Mohammad Khushtar. Hepatoprotective potential of Salacia oblonga root against antitubercular drug-induced hepatotoxicity: An in vivo approach. Biocatalysis and Agricultural Biotechnology 2025; 70 doi: 10.1016/j.bcab.2025.103874
|
| 9 |
Shunling Yuan, Jiaxin Liu, Jiyou Wu, Jianhui He, Liangwu Qiu. Exercise attenuates high-fat diet-induced liver injury in mice via PPARα pathway and reduction of oxidative stress and inflammation. Journal of Physiology and Biochemistry 2026; 82(1) doi: 10.1007/s13105-026-01167-1
|
| 10 |
Feifei Lu, Yao Meng, Xiaoting Song, Xiaotong Li, Zhuang Liu, Chunru Gu, Xiaojie Zheng, Yi Jing, Wei Cai, Kanokwan Pinyopornpanish, Andrea Mancuso, Fernando Gomes Romeiro, Nahum Méndez-Sánchez, Xingshun Qi. Artificial Intelligence in Liver Diseases: Recent Advances. Advances in Therapy 2024; 41(3) doi: 10.1007/s12325-024-02781-5
|
| 11 |
Li-jiao Sun, Xin Chen, Sai Zhu, Jin-jin Xu, Xiao-feng Li, Shao-xi Diao, Ying-li Yang, Jin-yu Liu, Jia-nan Wang, Ying-yin Sun, Cheng Huang, Xiao-ming Meng, Hua Wang, Xiong-wen Lv, Jun Li. Hesperetin derivative 2a inhibits lipopolysaccharide-induced acute liver injury in mice via downregulation of circDcbld2. Acta Pharmacologica Sinica 2024; 45(2) doi: 10.1038/s41401-023-01171-x
|
| 12 |
Duaa A. Althumairy. Green-Synthesized Silver Nanoparticles from Garlic Peel Target NF-κB and Redox Imbalance: A Novel Therapeutic Strategy Against Pyrogallol-Induced Hepatotoxicity in Rats. Nanomaterials 2025; 15(21) doi: 10.3390/nano15211610
|
| 13 |
Jin-can Huang, Yang Zhao, Yu-di Han, Zheng Xia, Guo-sheng Du, Ren Lang, Lin Zhou. CD8 regulatory T cells are a novel type regulatory T cells in the induction of transplantation immune tolerance. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1829051
|
| 14 |
Valentin Blank, Thomas Karlas, Ulf Anderegg, Johannes Wiegand, Josi Arnold, Linnaeus Bundalian, Gabriela‐Diana Le Duc, Christiane Körner, Thomas Ebert, Anja Saalbach. Thy‐1 restricts steatosis and liver fibrosis in steatotic liver disease. Liver International 2024; 44(8) doi: 10.1111/liv.15956
|
| 15 |
Agata Michalak, Tomasz Lach, Karolina Szczygieł, Halina Cichoż-Lach. COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?. International Journal of Molecular Sciences 2024; 25(4) doi: 10.3390/ijms25042212
|
| 16 |
Moeen ud din Khan Khalil, Syed Kazim Shah Bukhari, Syed Murtaza Shah Bukhari, Mian Zia Shah, Mian Raza Shah. Correlation between computed tomography findings and liver function parameters in chronic liver disease. Journal of Shalamar Medical & Dental College - JSHMDC 2025; 6(1) doi: 10.53685/jshmdc.v6i1.308
|
| 17 |
Mona M. AbouSamra. Liposomal nano-carriers mediated targeting of liver disorders: mechanisms and applications. Journal of Liposome Research 2024; 34(4) doi: 10.1080/08982104.2024.2377085
|
| 18 |
Nadia Ghazanfar. Liver trauma management: a review of long-term outcome, advanced imaging, and comorbidities. Ghalib Medical Journal 2026; doi: 10.58342/MJ.V.3.I.1.15
|
| 19 |
Yakun Li, Jia Li, Robin P. F. Dullaart, Han Moshage. Bacterial Extracellular Vesicles in the Pathogenesis and Treatment of Liver Diseases. Journal of Gastroenterology and Hepatology 2026; 41(3) doi: 10.1111/jgh.70264
|
| 20 |
Eiman M. Adly, Thoria Diab, Mohamed Hessien. Dexamethasone-boosted mesenchymal stem cell secretome: insight into hepatic protection. BMC Biotechnology 2025; 25(1) doi: 10.1186/s12896-025-00980-8
|
| 21 |
Khaled A. Nematallah, Amgad Albohy, Noha Swilam. Phytotherapeutic approach to enhance the hepatoprotective activity of some edible plants: Molecular docking and nanoformulation. Journal of Functional Foods 2024; 122 doi: 10.1016/j.jff.2024.106471
|
| 22 |
Darya Pon`kina, Sergey Kuranov, Mikhail Khvostov, Nataliya Zhukova, Yulia Meshkova, Mariya Marenina, Olga Luzina, Tatyana Tolstikova, Nariman Salakhutdinov. Hepatoprotective Effect of a New FFAR1 Agonist—N-Alkylated Isobornylamine. Molecules 2023; 28(1) doi: 10.3390/molecules28010396
|
| 23 |
Trilochan Satapathy, Mansi Verma, Poonam Sahu, Anjali Minj. Therapeutic potential of gallic acid and diosgenin in metabolic dysfunction-associated steatotic liver disease (MASLD) and non-alcoholic fatty liver disease (NAFLD): A comprehensive review. Pharmacological Research - Natural Products 2026; 10 doi: 10.1016/j.prenap.2026.100525
|
| 24 |
Kshama Gupta, Prasad Mamidi. Ayurvedic management of chronic liver disease with portal hypertension and hepatic encephalopathy - A case report. International Journal of Complementary & Alternative Medicine 2023; 16(5) doi: 10.15406/ijcam.2023.16.00659
|
| 25 |
Daisuke Usuda, Yuki Kaneoka, Rikuo Ono, Masashi Kato, Yuto Sugawara, Runa Shimizu, Tomotari Inami, Eri Nakajima, Shiho Tsuge, Riki Sakurai, Kenji Kawai, Shun Matsubara, Risa Tanaka, Makoto Suzuki, Shintaro Shimozawa, Yuta Hotchi, Ippei Osugi, Risa Katou, Sakurako Ito, Kentaro Mishima, Akihiko Kondo, Keiko Mizuno, Hiroki Takami, Takayuki Komatsu, Tomohisa Nomura, Manabu Sugita. Current perspectives of viral hepatitis. World Journal of Gastroenterology 2024; 30(18): 2402-2417 doi: 10.3748/wjg.v30.i18.2402
|
| 26 |
Anton Volniansky, Thierry L. Lefebvre, Merve Kulbay, Boyan Fan, Emre Aslan, Kim-Nhien Vu, Emmanuel Montagnon, Bich Ngoc Nguyen, Giada Sebastiani, Jeanne-Marie Giard, Marie-Pierre Sylvestre, Guillaume Gilbert, Guy Cloutier, An Tang. Inter-visit and inter-reader reproducibility of multi-parametric diffusion-weighted MR imaging in longitudinally imaged patients with metabolic dysfunction-associated fatty liver disease and healthy volunteers.. Magnetic Resonance Imaging 2024; 113 doi: 10.1016/j.mri.2024.110223
|
| 27 |
Devanshi D. Dave, Pardis Taheri, Sri Rahavi Boovarahan, Joohyun Kim, Allen W. Cowley, Said H. Audi, Ranjan K. Dash. Sex dimorphism and substrate dependency of liver mitochondrial bioenergetics and H2O2 production. American Journal of Physiology-Gastrointestinal and Liver Physiology 2025; 329(6) doi: 10.1152/ajpgi.00196.2025
|
| 28 |
Sabah Kulsum, Sajjad Ahmed Khan, Hema Sameera Pinnam, Harshita Malik, Hassam Ali, Dushyant Singh Dahiya. CRISPR and the Promise of Gene Editing: Unlocking Curative Possibilities for Liver Disorders Worldwide. ACG Case Reports Journal 2026; 13(4) doi: 10.14309/crj.0000000000002061
|
| 29 |
Yu Jia, Yuyi Zhang, Shirui Chen, Zehua Jia, Tongdi Fang, Jiayi Zhang, Zhiyong Guo. Avatrombopag Elevates Platelet Counts and Reduces Platelet Transfusions in Patients With Chronic Liver Diseases During the Perioperative Period of Liver Transplantation. Organ Medicine 2024; 1(1) doi: 10.1002/orm2.10
|
| 30 |
Mahmoud Khalil, Reem Elhamammy, Hanan Ragab, Mohamed Abdelgalil, Eman Sheta, Ahmed Elaraby, Tamer Ibrahim, Ahmed Wahid. Hepatoprotective Effects of Fused Pyridine Derivatives: Regulation of the TGF-β/Smad, miR-21/Smad7, and PPARγ Pathways in Carbon Tetrachloride-Induced Liver Fibrosis. Drug Design, Development and Therapy 2026; doi: 10.2147/DDDT.S592956
|
| 31 |
Jie Huang, Ding-Wei Xu, Ao Li. Can laparoscopic splenectomy and azygoportal disconnection be safely performed in patients presenting with cirrhosis, hypersplenism and gastroesophageal variceal bleeding? How to do it, tips and tricks (with videos). Current Problems in Surgery 2024; 61(7) doi: 10.1016/j.cpsurg.2024.101501
|
| 32 |
Anton Volniansky, Thierry L. Lefebvre, Merve Kulbay, Guillaume Gilbert, Boyan Fan, Justine Racette, Emmanuel Montagnon, Damien Olivié, Giada Sebastiani, Jeanne‐Marie Giard, Marie‐Pierre Sylvestre, Bich Ngoc Nguyen, Guy Cloutier, An Tang. Prospective Comparison of DWI‐Derived Virtual MR Elastography and Conventional MR Elastography in Metabolic Dysfunction‐Associated Steatotic Liver Disease and Healthy Volunteers. Journal of Magnetic Resonance Imaging 2026; 63(4) doi: 10.1002/jmri.70192
|
| 33 |
Ferdinand Bittner, Thomas Altmann, Michael Weitersberger, Sabrina Hettegger, Alexander Ziachehabi, Rainer Schöfl. Indikationen, Durchführung, Ergebnisse und Komplikationen eines transjugulären portosystemischen Shunts (TIPS). Journal für Gastroenterologische und Hepatologische Erkrankungen 2025; 23(2) doi: 10.1007/s41971-025-00227-5
|
| 34 |
Phool Chandra, Rashmi Pathak, Neetu Sachan, Ashok Kumar Gupta, Anurag Verma. Bioactive‐Based Nanotherapeutics. 2025; doi: 10.1002/9781394287345.ch7
|
| 35 |
EVALUATION OF HEPATOPROTECTIVE EFFECT OF CYMBIDIUM ALOIFOLIUM (L.) SW EXTRACTS ON ETHYL ALCOHOL-INDUCED HEPATOTOXICITY IN RODENTS. Asian Journal of Pharmaceutical and Clinical Research 2026; doi: 10.22159/ajpcr.2026v19i2.57144
|